A modest daily intake of vitamin may aid in prevention of the most common types of skin cancer, rendered a new Australian research.
A University of Sydney study founded that nicotinamide, a vitamin B3 form, reduced incidence up to 23 % of a new non-melanoma skin cancers in people who had two of the cancers, five years previously.
The findings offer another option for reduction of the burden and cost of skin cancer, the commonest form of the disease for fair-skinned people, said the American Society of Clinical Oncology, which released the study on Wednesday, ahead of their annual meeting by this month’s end.
“It’s a cheap vitamin,” Dr Peter Paul Yu, said, the ASCO president and director of cancer research at Palo Alto Medical Foundation.
UV radiation exposure from the sun is the major cause of non-melanoma skin cancer which destroys DNA cells and destroys the skin’s immune system to eliminate abnormal cells.
Study shows that nicotinamide lessens the risk for basal and squamous cell carcinomas.
As early as three months after treatment started, the preventive effect began, but stopped after the patient also stopped taking the vitamin, demonstrating a “need for continuous tablet intake for them to be effective,”
The researchers cautioned people need to use sunblock and conduct regular skin cancer screening, especially for those at high risk of the disease.
Squamous and basal cell carcinomas may be the most common skin cancers, but melanoma is the deadliest of all forms of skin cancer.